-+ 0.00%
-+ 0.00%
-+ 0.00%

*Amanat: Corxel's Lead Pdt Candidate, CX11, Is an Investigational, Once-Daily, Oral Small-Molecule GLP-1 RA Being Developed for Obesity, Type 2 Diabetes, Related Cardiometabolic Conditions >AMAN

Dow Jones·10/26/2026 10:07:00

请登录查看新闻详情